Thursday, March 25, 2004 2:24:50 PM
And while HGS is changing their direction and cutting back on their drug development pipeline to focus on a few potential winners, they've been in the business for 14 years. It's only been a relatively short time that DNAP announced the validation of their discovery platform, successfully brought two innovative products to market, and recently announced the $8 million dollar funding from La Jolla and DNAP's intentions to start infusing their drug development and clinical trials...so be fair and give them a few more years and come back to compare them then...lol!
Meanwhile, I'll pick DNAP and their revolutionary ADMIXMAP discovery platform at .05 cents per share over any of the big biotechs or pharma's...any day......! The potential for incredible returns on my investment at this price if DNAP is successful with even just one winner is awesome...
I really like my odds...
God Bless and Take Care,
Robert
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM